Justification (Sole Source)Posted Oct 6, 2025

Q301--ThyroSeq v3 Genomic Classifier Base | 583C62031

Veterans Affairs · 250-NETWORK CONTRACT OFFICE 10 (36C250)

Stage
Justification for other than full competition
NAICS
621511
Value
$387K
Solicitation
36C25025Q0934
Set-aside
None stated
PSC
Q301
Place
Not stated
Contact
Jessica Bryant (Jessica.Bryant5@va.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 36C25025Q0934 in this department, oldest first.

Early notice
  • Sep 15, 2025
    Special Notice
    Open
Solicitation
None posted
Award
  • Oct 6, 2025
    Award Notice
    CYTOPATH BIOPSY LAB INC · $387K
    Open
Other notices
  • Oct 6, 2025 · this notice
    Justification (Sole Source)
    CYTOPATH BIOPSY LAB INC · $387K

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • The agency intends to buy without full competition. Read the justification for the reason and the named source.

What the notice says

Justification and Approval for the award of the ThyroSeq V3 Genomic Classifier thyroid testing with the Richard L. Roudebush VA Medical Center.

Who won similar work

8 award notices on SAM.gov in the last 24 months. Matched by: Same office (250-NETWORK CONTRACT OFFICE 10 (36C250)), same product/service code (PSC) Q301 and NAICS 621511.

Single-winner award sizes (8): middle half $219K to $3.1M, median $1.3M; range $130K to $4.6M.

WinnerAwardsValueLast
LABORATORY CORPORATION4$13.7MAug 31, 2026
MAYO COLLABORATIVE SERVICES, INC.1$275KApr 20, 2026
ADAPTIVE BIOTECHNOLOGIES CORPORATION · $ADPT · $308.1M1$244KDec 30, 2025
CYTOPATH BIOPSY LAB INC1$146KDec 23, 2025
VERACYTE LABS SD CORPORATION · $VCYT · $561.9M1$130KNov 19, 2025

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

Investor context
  • $ADPT reported $308.1M revenue (12 months to Jun 30, 2026). The median single-winner award in these 8 past awards, $1.3M, is 0.4% of that. SEC filing
  • $VCYT reported $561.9M revenue (12 months to Jun 30, 2026). The median single-winner award in these 8 past awards, $1.3M, is 0.2% of that. SEC filing

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 5 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 25 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 2 of the past winners are listed companies
  • 0 insider buys and 14 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.